Got $1,000? 2 No-Brainer Nuclear Stocks to Buy Right Now.

Oklo offers higher-risk nuclear-reactor exposure, with analysts implying up to 230% 12-month upside despite only $1.21 million of Q2 revenue, $74 million in operating expenses, and a $124.2 million operating loss in early 2026. Cameco provides a more established alternative, with contracts for more than 28 million pounds of annual uranium deliveries from 2026-2030 and C$676 million ($483 million) of first-half 2026 uranium adjusted EBITDA. Rising electricity demand—projected at 3.6% annually globally through 2030 and driven substantially by data centers—supports both companies, while Cameco's consensus strong-buy rating and up to 55% target-price upside reflect its steadier operating profile.

Analysis

The investable distinction is not simply uranium versus advanced reactors: CCJ monetizes the nuclear buildout before new capacity is commissioned, while OKLO requires successful licensing, fuel qualification, project financing, construction execution, and creditworthy offtake conversion before its valuation can be anchored to operating cash flow. CCJ's Westinghouse exposure also creates a higher-quality earnings mix than spot-uranium proxies, but makes its upside more dependent on reactor-life-extension and service awards than on uranium-price beta alone. Near term, this favors CCJ if utilities continue contracting fuel security ahead of reactor decisions.

OKLO is effectively a long-duration option on hyperscaler power scarcity. A credible binding power purchase agreement, NRC licensing milestone, or non-dilutive project-finance structure could re-rate the equity sharply over 1-3 months; absent these, cash burn and the cost of capital are likely to dominate over the next 6-18 months. The key second-order constraint is fuel: advanced-reactor deployment competes for scarce HALEU supply, so reactor announcements without funded fuel access should not be treated as deployable capacity.

Consensus may be underestimating the bottleneck shift from uranium availability to transmission, interconnection, and delivery timing. Hyperscalers needing firm power this decade may prefer immediately contractible alternatives—gas generation, grid-connected renewables plus storage, or conventional nuclear uprates—rather than wait for first-of-a-kind SMR schedules. This creates a risk that high-profile data-center agreements support OKLO's narrative multiple well before they support revenue, leaving the stock unusually exposed to any schedule slip or equity issuance.

Key Decisions for Investors

• Prefer long CCJ over OKLO for a 6-12 month nuclear allocation; CCJ offers nearer-term contracted-volume and services earnings support, while OKLO remains principally milestone-driven. Reassess if uranium term-contracting weakens materially or Westinghouse order/service backlog disappoints.
• Use a paired expression: long CCJ / short OKLO in equal dollar amounts over the next 1-3 months if OKLO rallies on non-binding data-center or licensing headlines. Thesis is cash-generative fuel/services exposure versus duration-heavy development risk; cover the short upon a binding, financed offtake-plus-construction package or a definitive licensing approval.
• Treat OKLO as an event watch, not a core long, until management discloses funded runway, expected project capital intensity, HALEU sourcing terms, and contracted economics. If these are verified, use defined-risk call spreads rather than common equity because binary regulatory and financing outcomes can produce large downside gaps.
• Monitor META's disclosed power-procurement commitments and regional interconnection timelines over the next two quarters. A shift toward gas, conventional nuclear services, or utility-owned supply would weaken the implied near-term SMR demand case; a long-duration, credit-backed nuclear PPA would be the relevant confirmation catalyst.